The article contains sections titled:
1.
Introduction
2.
J05A Direct Acting Antivirals
2.1.
J05AB Nucleosides and Nucleotides excluding RTIs
2.2.
J05AC Cyclic Amines
2.3.
J05AD Phosphonic Acid Derivatives
2.4.
J05AE Protease Inhibitors
2.5.
J05AF Nucleoside and Nucleotide RTIs; NRTIs
2.6.
J05AG Non‐Nucleoside RTIs; NNRTIs
2.7.
J05AH Neuraminidase Inhibitors
2.8.
J05AR Antivirals for Treatment of HIV Infections, Combinations
2.9.
J05AX Other Antivirals